Kathy A. Steece-Collier, Ph.D.
Affiliations: | Translational Science & Molecular Medicine | Michigan State University, East Lansing, MI |
Area:
Parkinson's disease / dyskinesias / synaptic reorganizationGoogle:
"Kathy Steece-Collier"Mean distance: 16.92 (cluster 6) | S | N | B | C | P |
Collaborators
Sign in to add collaborator| Jack W. Lipton | collaborator | Michigan State | |
| Caryl E. Sortwell | collaborator | Michigan State |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Patterson JR, Hirst WD, Howe JW, et al. (2022) Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. Npj Parkinson's Disease. 8: 61 |
| Caulfield ME, Stancati JA, Steece-Collier K. (2021) Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease. Journal of Visualized Experiments : Jove |
| Cole TA, Zhao H, Collier TJ, et al. (2021) α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease. Jci Insight. 6 |
| Miller KM, Patterson JR, Kochmanski J, et al. (2021) Striatal afferent BDNF is disrupted by synucleinopathy and partially restored by STN DBS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
| Mercado NM, Stancati JA, Sortwell CE, et al. (2020) The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats. Neurobiology of Disease. 105175 |
| Bartlett MJ, Flores AJ, Ye T, et al. (2020) Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia. Experimental Neurology. 113413 |
| Steece-Collier K, Collier TJ, Lipton JW, et al. (2020) Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in fisher 344 vs. Lewis hemiparkinsonian rats. Experimental Neurology. 113327 |
| Sellnow RC, Steece-Collier K, Altwal F, et al. (2020) Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
| Collier TJ, Sortwell CE, Mercado NM, et al. (2019) Cell therapy for Parkinson's disease: Why it doesn't work every time. Movement Disorders : Official Journal of the Movement Disorder Society |
| Steece-Collier K, Stancati JA, Collier NJ, et al. (2019) Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society |